FDA Approves First Antisense Therapy for Chronic Hepatitis BOctober 20, 2026 Health 2 Views The FDA approved Hibsago, the first antisense oligonucleotide for chronic hepatitis b treatment, allowing some patients to stop therapy while maintaining viral control.
